| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
382 |
359 |
$27K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
142 |
131 |
$7K |
| 99215 |
Prolong outpt/office vis |
73 |
72 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
95 |
88 |
$2K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
49 |
45 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
82 |
78 |
$1K |
| 99407 |
|
79 |
76 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
46 |
46 |
$191.80 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
43 |
39 |
$133.24 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
123 |
116 |
$47.84 |
| 36415 |
Collection of venous blood by venipuncture |
18 |
13 |
$2.70 |
| J7638 |
Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
23 |
17 |
$0.09 |
| 1125F |
|
606 |
545 |
$0.00 |
| 1034F |
|
213 |
197 |
$0.00 |
| 2000F |
|
431 |
389 |
$0.00 |
| 3008F |
|
390 |
350 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
23 |
17 |
$0.00 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
21 |
17 |
$0.00 |